EdgarLookup

MindWalk Holdings Corp. — All Filings

257 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 20-F 20-F/A 40-F 40-F/A 40FR12B 40FR12B/A 424B5 6-K 6-K/A CERT CORRESP D EFFECT F-10 F-10/A F-3 F-X FWP S-8 SC 13D SC 13G SC 13G/A SCHEDULE 13G/A SEC STAFF ACTION SUPPL UPLOAD
Form Description Accession Number Filed Period
6-K 6-K 0001193125-21-313125 Oct 29, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. FORM 6-K 0001157523-21-001198 Oct 14, 2021 Oct 13, 2021
6-K 6-K 0001193125-21-297961 Oct 13, 2021
SUPPL SUPPL 0001193125-21-297960 Oct 13, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-001190 Oct 7, 2021
40-F/A 40-F/A 0001564590-21-049295 Sep 29, 2021 Apr 30, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-001131 Sep 9, 2021
6-K IPA FY22 Q1 6-K FILING 0001564590-21-047413 Sep 9, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-001128 Sep 8, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-001123 Sep 7, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. FORM 6-K 0001157523-21-001117 Sep 3, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000993 Aug 4, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000937 Jul 28, 2021
40-F 40-F 0001564590-21-038477 Jul 28, 2021 Apr 30, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000902 Jul 22, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000875 Jul 15, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000816 Jun 22, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000798 Jun 17, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000790 Jun 15, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. FORM 6-K 0001157523-21-000735 Jun 3, 2021 Jun 2, 2021
S-8 S-8 0001193125-21-180096 Jun 2, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000712 May 25, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000696 May 20, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000483 Apr 21, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000438 Apr 8, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000382 Mar 25, 2021
6-K 6-K 0001564590-21-013991 Mar 18, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. FORM 6-K 0001157523-21-000357 Mar 18, 2021 Mar 17, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000343 Mar 16, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000296 Mar 4, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000224 Feb 19, 2021
6-K 6-K 0001193125-21-036661 Feb 11, 2021 Feb 10, 2021
6-K 6-K 0001193125-21-032411 Feb 8, 2021
6-K 6-K 0001193125-21-028979 Feb 4, 2021
SUPPL SUPPL 0001193125-21-028966 Feb 4, 2021
FWP FWP 0001193125-21-027765 Feb 4, 2021
FWP FWP 0001193125-21-027511 Feb 4, 2021
SUPPL SUPPL 0001193125-21-027375 Feb 3, 2021
6-K 6-K 0001193125-21-027348 Feb 3, 2021 Feb 1, 2021
EFFECT 9999999995-21-000104 Jan 11, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000021 Jan 7, 2021 Jan 6, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-21-000015 Jan 6, 2021
F-10/A F-10/A 0001193125-21-002077 Jan 5, 2021
6-K IMMUNOPRECISE ANTIBODIES LTD. 6-K 0001157523-20-001631 Dec 30, 2020
SEC STAFF ACTION 9999999997-20-005906 Dec 29, 2020
40FR12B/A 40FR12B/A 0001193125-20-327628 Dec 28, 2020
CERT 0001354457-20-000836 Dec 28, 2020
40FR12B/A 40FR12B/A 0001193125-20-324051 Dec 22, 2020
F-X F-X 0001193125-20-288582 Nov 9, 2020
F-10 F-10 0001193125-20-288544 Nov 9, 2020